D5kjvxkzvac24qvo223a

LuerJack in Norway - ConceptoMed AS and Vingmed AS signed a marketing, sales and distribution agreement for the hospital market

Press Releases   •   Nov 06, 2017 15:16 GMT

ConceptoMed AS is delighted to announce a new partner for the Norwegian hospital market. We have entered into a distribution agreement with Vingmed AS granting exclusive rights for marketing, sales and distribution of the LuerJack syringes in the hospital market in Norway.

Kzaof9uxhqnvdxggaige

LuerJack Lock - US FDA 510(k) cleared

Press Releases   •   Sep 11, 2017 15:24 BST

ConceptoMed AS has received FDA 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the LuerJack Slip syringes and the first LuerJack Lock 10ml syringe.

Hqpbzijx0nh80xmj4nak

LuerJack in Iceland - ConceptoMed and Heilsuland ehf. signed a marketing, sales and distribution agreement

Press Releases   •   May 02, 2017 16:52 BST

ConceptoMed announces that it has entered into a distribution agreement with Heilsuland ehf. The agreement gives Heilsuland ehf. the exclusive rights to marketing, sales and distribution of the LuerJack syringes in Iceland.

U0limwgxyo8i7lh8amyk

Wego Group and ConceptoMed signed Memorandum of Understanding

Press Releases   •   Apr 08, 2017 08:08 BST

​On the 8th of April 2017, in the presence of Her Excellency Erna Solberg, Prime Minister of Norway, on her first official visit to the People’s Republic of China, Wego Group and ConceptoMed AS signed a Memorandum of Understanding. Wego Group and ConceptoMed wish to explore the possibility of entering into a business relationship, either manufacturing or other strategic collaboration.

Utinfbramu2vjka1knd6

Chinese Patent issued for LuerJack

Press Releases   •   Apr 06, 2017 12:41 BST

On the 14th of February 2017, the Chinese Patent and Trademark office issued an official document granting the Chinese patent for LuerJack. ConceptoMed’s strategy to protect our intellectual property rights (IPR) remains unchanged and strong. Along with other markets already protected, such as Europe, the US, Australia and Mexico, protection in Asia is now following.

Media no image

LuerJack in Portugal - ConceptoMed and BioBrites Lda signed a marketing, sales and distribution agreement

Press Releases   •   Apr 05, 2017 14:30 BST

ConceptoMed announces that it has entered into a distribution agreement with BioBrites Lda. The agreement gives BioBrites the exclusive rights to marketing, sales and distribution of the LuerJack syringes in Portugal.

BioBrites Lda is a Portuguese medical wholesaler, supplying medical equipment and consumables to public hospitals in all of Portugal. Their focus business areas are neurosurgery, ENT, general surgery, hygiene and infection control. BioBrites Lda is already the distributor of key products from Dr.Schumacher.

Visit: www.biobrites.pt

This distribution agreement strengthens ConceptoMed’s strategy to reach a global distribution and offer an alternative to the conventional medical syringes’ marked worldwide.

Despite the increased focus on infection control, healthcare acquired bloodstream infections are still an important issue. The LuerJack system prevents accidental cross contamination, representing a large proportion of healthcare related infections. The LuerJack syringe is the only syringe designed with a one-hand disconnection capability. Its integrated one-hand ’Click and Release’ function significantly reduces the risk of human error. It enables a fast, safe and more efficient disconnection from the needle or any other medical attachments, and thereby reduces dramatically the risk of needlestick injuries.

BioBrites is the perfect sales, marketing and distribution partner for LuerJack in the Portuguese healthcare market. Their track record of introducing important medical innovations to healthcare professionals is outstanding. Their high focus on hygiene and infection control is a perfect match to the benefits that LuerJack brings.
“We really look forward to contribute to improve infection prevention and patient safety in Portugal”, said Christian Mide, M.D., CEO and founder of ConceptoMed.

For more information, please visit www.luerjack.com and/or contact:

Christian Mide, CEO-christian.mide@conceptomed.com+47 95 100 720
Paulo Jorge Brites, CEO-geral@biobrites.pt+351 910 542 2222
Ann-Christine Jungmar, CCO-ann-christine.jungmar@conceptomed.com+46 708 71 46 76

ConceptoMed AS is an ISO 13485 certified, ambitious medtech company serving the global market with innovative product categories and unique proprietary technology. We create smart medtech systems that empower healthcare professionals and improve patient care. Excellence through simplicity is our code. We are brave, curious and dedicated. We simply care.

Based in Norway, the team is continuously meeting milestones and expanding its activities for international growth.
For more information on the company and career opportunities, see www.conceptomed.com and www.luerjack.com.
Follow us on MyNewsdesk and LinkedIn.

Luer-Jack® is a registered trademark owned by ConceptoMed AS. The Luer-Jack® technology is widely patent protected throughout the world, currently with > 60 patents (granted and pending) from 8 patent families.

ConceptoMed announces that it has entered into a distribution agreement with BioBrites Lda. The agreement gives BioBrites the exclusive rights to marketing, sales and distribution of the LuerJack syringes in Portugal.

Read more »
Shlczjyydrnnoccbgeiq

US FDA 510(k) Clearance for Luer-Jack® Slip syringe

Press Releases   •   Jan 13, 2017 16:32 GMT

ConceptoMed AS received FDA 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the first size of the Luer-Jack® syringe.

H3tyavff16fs6pmcvmkw

Luer-Jack secures Sterigenics Sterilization Services Agreement

Press Releases   •   Dec 22, 2016 11:35 GMT

In December 2016, ConceptoMed have entered into important collaborations with suppliers of sterilization services (Sterigenics) and logistics & healthcare warehousing services (DSV Logistics) to secure the global strategy for ConceptoMed and Luer-Jack.

I7b5b5ahzlulqufdfwee

ConceptoMed named "Company of the Year 2016" of Norwegian Medtech Cluster

News   •   Dec 18, 2016 15:56 GMT

On Thursday 8th of December 2016, ConceptoMed was named Company of the Year 2016 among approx 190 members of Oslo Medtech, a health technology cluster dedicated to accelerate and support the development of new medtech and eHealth products, services and innovative solutions for the Norwegian and global health care market.

Bmqkzfots06qlc4rdowt

Luer-Jack high-volume production agreement with AB Euroform MediPharm, Sweden

Press Releases   •   Oct 31, 2016 11:01 GMT

On the 28th of October 2016, ConceptoMed and AB Euroform MediPharm entered into an agreement for high-volume capacity manufacturing for Luer-Jack. Euroform MediPharm is a ISO 13485 certified long-term partner within development and production of polymer products for world class customers in Pharmaceutical and Medical Technology industries.

Contacts 2 contacts

  • Press Contact
  • Chief Commercial & Business Development
  • xhanbanyn-chnnvsuyriyvstqhwwinnue.jungmar@coxpncvereeptomesyawxomhd.jscowvm
  • +46 70-871 46 76
  • +47 76089000

About ConceptoMed AS

Excellence through Simplicity!

ConceptoMed AS is a ISO 13485 certified, ambitious medtech company serving the global market with innovative product categories and unique proprietary technology. We create smart medtech systems that empower healthcare professionals and improve patient care. Excellence through simplicity is our code. We are brave, curious and dedicated. We simply care.
Based in Norway, the team is continuously meeting milestones and expanding its activities for international growth.
For more information on the company and career opportunities, see www.conceptomed.com and www.luerjack.com. Follow us on MyNewsdesk and LinkedIn.

Luer-Jack® is a registered trademark owned by ConceptoMed AS. The Luer-Jack® technology is widely patent protected throughout the world, currently with almost 50 patents (granted and pending) from 8 patent families.

Address

  • ConceptoMed AS
  • Hattvikveien 2
  • 8373 Ballstad
  • Norway